Dear Democracy Now! Visitor: We are an independent, ad-free daily news program that serves millions of viewers and listeners each month. In this US election year, Democracy Now! is more important than ever. For 20 years, we’ve put a spotlight on corporate and government abuses of power. We lift up the stories of ordinary people working to make change in extraordinary times. We do all of this with just a fraction of the budget and staff of a commercial news show. We do it without ads, corporate sponsorship or government funding. How is this possible? Only with your support. A generous funder will match your donation dollar for dollar if you donate right now. That means when you give $10, your donation will be worth $20. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you every day.

Your Donation: $

Big Losses for Big Tobacco Or Not?

July 18, 2000

It is a number that has captured the attention of the nation–$145 billion. It’s big enough that it sounds like a tax bill being debated in Congress or some new Pentagon project. But, in fact, it is the amount that a Florida jury has ruled that tobacco companies have to pay for damage caused to smokers in the state–and it’s raising a fundamental question: Can Big Tobacco survive it?

To some, the award is so startling— the equivalent of the gross domestic product of Portugal —that the industry will never be the same again. Others say it is a small price to pay for the close to half a million deaths every year in the US. That doesn’t include even larger numbers of people that are sick.


  • Ralph Della Vecchia, one of the lead plaintiffs in the class action lawsuit. He represents his wife who died of lung cancer at the age of 53.
  • Frank Amodeo, has throat cancer and is one of the lead plaintiffs.
  • Milo Geyelin, the Legal Reporter for the Wall Street Journal.
  • Gordon Fairclough, the Tobacco Reporter for the Wall Street Journal.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.